A study to evaluate whether the tocilizumab enhances regulatory t-cell activation and proliferation in giant cell arteritis.
Phase of Trial: Phase IV
Latest Information Update: 08 Feb 2016
At a glance
- Drugs Tocilizumab (Primary)
- Indications Giant cell arteritis
- Focus Biomarker; Pharmacodynamics
- 08 Feb 2016 New trial record